cbdMD, Inc. Achieves NYSE American Compliance: A Step Toward Future Growth

cbdMD, Inc. Achieves NYSE American Compliance

On December 8, 2025, cbdMD, Inc. (NYSE American: YCBD), a prominent name in the wellness and hemp-derived product industry, proudly announced that it has successfully regained compliance with the continued listing standards of NYSE American. This important achievement comes as the .BC indicator for noncompliance was officially removed, reflecting the company’s dedicated efforts to uphold its listing status, which is essential for maintaining investor confidence and market presence.

This compliance was confirmed in a letter from NYSE American on December 5, 2025, stating that all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide had been addressed. Ronan Kennedy, the Chief Executive Officer of cbdMD, expressed his excitement over this announcement, emphasizing that preserving their NYSE American listing represents a significant milestone for the company and its stakeholders. “It reflects our hard work to enhance our balance sheet and fortify our company for sustainable growth,” he stated.

cbdMD has implemented several critical strategies that contributed to this compliance. Among these were the conversion of Series A Preferred shares in May and a successful capital raise in September. These efforts not only demonstrated a strong commitment from investors but also highlighted the company’s long-term vision for success. Kennedy applauded the constructive engagement provided by NYSE American throughout the process and reaffirmed that cbdMD is dedicated to generating long-term value for its shareholders as it moves forward.

The company will now continue to adhere to NYSE American's ongoing listing monitoring protocols, vowing to maintain robust financial discipline and governance as part of their operational focus. This renewed commitment is aimed at ensuring that cbdMD remains a respected player in the rapidly changing cannabis market, which has seen an influx of new companies vying for attention among consumers and investors alike.

In addition to their successful compliance efforts, cbdMD is well-known for its extensive product line that includes trusted and recognized cannabidiol (CBD) offerings. Their portfolio consists of a variety of U.S.-produced CBD products, as well as offerings compliant with the Farm Act surrounding Delta 9 products. Of note is their Paw CBD brand, which is tailored for pets and features veterinarian-formulated products, as well as their innovative Herbal Oasis brand, which caters to consumers looking for THC-infused beverages.

To learn more about cbdMD’s array of hemp-derived products, consumers are encouraged to visit their official site as well as their various associated brands, including Paw CBD and Herbal Oasis. This broad range of offerings positions cbdMD to better serve the diverse needs of consumers seeking wellness solutions derived from hemp.

As cbdMD continues to push forward in compliance and product development, it remains optimistic about the future, viewing this compliance achievement not merely as a regulatory obligation but as a foundational step toward building an organization poised for future growth and ongoing success within the wellness industry. The company’s proactive stance showcases its commitment to navigating the complexities of the market while staying aligned with evolving regulations and consumer demands.

In conclusion, the recent success of cbdMD in regaining compliance with NYSE American listing standards is a testament to the hard work and determination of its team and stakeholders. With this reinforcement of their market position, cbdMD is ready to embrace the challenges and opportunities that lie ahead in the ever-evolving landscape of wellness products, ensuring they maintain their reputation as a leading brand within the CBD space. Supplying high-quality and compliant products will remain a cornerstone of their operations as they continue to prioritize customer satisfaction and product innovation in a competitive marketplace.